Patent · US Active

2-benzylpyridazinone derivatives as met kinase inhibitors

US8557813B2 · kind B2 · utility

2Cited by

4References

15Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Dieter Dorsch · Ober-Ramstadt, DE
Oliver Schadt · Rodenbach, DE
Frank Stieber · Heidelberg, DE
Andree Blaukat · Heilbad Heiligenstadt, DE

Key dates

Filing date	Nov 25, 2008
Grant date	Oct 15, 2013
Priority date	—
Expiry date	Aug 17, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula Iin which R1, R2, R3, R4′ have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.